These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
363 related articles for article (PubMed ID: 7534417)
21. Mapping of epitopes, glycosylation sites, and complement regulatory domains in human decay accelerating factor. Coyne KE; Hall SE; Thompson S; Arce MA; Kinoshita T; Fujita T; Anstee DJ; Rosse W; Lublin DM J Immunol; 1992 Nov; 149(9):2906-13. PubMed ID: 1383332 [TBL] [Abstract][Full Text] [Related]
22. Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. Naniche D; Varior-Krishnan G; Cervoni F; Wild TF; Rossi B; Rabourdin-Combe C; Gerlier D J Virol; 1993 Oct; 67(10):6025-32. PubMed ID: 8371352 [TBL] [Abstract][Full Text] [Related]
23. Interaction of measles virus (Hallé strain) with CD46: evidence that a common binding site on CD46 facilitates both CD46 downregulation and MV infection. Lecouturier V; Rizzitelli A; Fayolle J; Daviet L; Wild FT; Buckland R Biochem Biophys Res Commun; 1999 Oct; 264(1):268-75. PubMed ID: 10527876 [TBL] [Abstract][Full Text] [Related]
24. Differential receptor usage by measles virus strains. Bartz R; Firsching R; Rima B; ter Meulen V; Schneider-Schaulies J J Gen Virol; 1998 May; 79 ( Pt 5)():1015-25. PubMed ID: 9603316 [TBL] [Abstract][Full Text] [Related]
25. Octamerization enables soluble CD46 receptor to neutralize measles virus in vitro and in vivo. Christiansen D; Devaux P; Réveil B; Evlashev A; Horvat B; Lamy J; Rabourdin-Combe C; Cohen JH; Gerlier D J Virol; 2000 May; 74(10):4672-8. PubMed ID: 10775604 [TBL] [Abstract][Full Text] [Related]
26. Identification of the streptococcal M protein binding site on membrane cofactor protein (CD46). Giannakis E; Jokiranta TS; Ormsby RJ; Duthy TG; Male DA; Christiansen D; Fischetti VA; Bagley C; Loveland BE; Gordon DL J Immunol; 2002 May; 168(9):4585-92. PubMed ID: 11971006 [TBL] [Abstract][Full Text] [Related]
27. Evidence for distinct complement regulatory and measles virus binding sites on CD46 SCR2. Christiansen D; Deléage G; Gerlier D Eur J Immunol; 2000 Dec; 30(12):3457-62. PubMed ID: 11093164 [TBL] [Abstract][Full Text] [Related]
28. CD46 short consensus repeats III and IV enhance measles virus binding but impair soluble hemagglutinin binding. Devaux P; Buchholz CJ; Schneider U; Escoffier C; Cattaneo R; Gerlier D J Virol; 1997 May; 71(5):4157-60. PubMed ID: 9094700 [TBL] [Abstract][Full Text] [Related]
29. Expression of a hybrid complement regulatory protein, membrane cofactor protein decay accelerating factor on Chinese hamster ovary. Comparison of its regulatory effect with those of decay accelerating factor and membrane cofactor protein. Iwata K; Seya T; Ariga H; Nagasawa S J Immunol; 1994 Apr; 152(7):3436-44. PubMed ID: 7511647 [TBL] [Abstract][Full Text] [Related]
30. Physical association of moesin and CD46 as a receptor complex for measles virus. Schneider-Schaulies J; Dunster LM; Schwartz-Albiez R; Krohne G; ter Meulen V J Virol; 1995 Apr; 69(4):2248-56. PubMed ID: 7884872 [TBL] [Abstract][Full Text] [Related]
31. Molecular cloning of membrane cofactor protein (MCP; CD46) on B95a cell, an Epstein-Barr virus-transformed marmoset B cell line: B95a-MCP is susceptible to infection by the CAM, but not the Nagahata strain of the measles virus. Murakami Y; Seya T; Kurita M; Fukui A; Ueda S; Nagasawa S Biochem J; 1998 Mar; 330 ( Pt 3)(Pt 3):1351-9. PubMed ID: 9494106 [TBL] [Abstract][Full Text] [Related]
32. CD46 transgene expression in pig peripheral blood mononuclear cells does not alter their susceptibility to measles virus or their capacity to downregulate endogenous and transgenic CD46. Schneider-Schaulies J; Martin MJ; Logan JS; Firsching R; ter Meulen V; Diamond LE J Gen Virol; 2000 Jun; 81(Pt 6):1431-8. PubMed ID: 10811926 [TBL] [Abstract][Full Text] [Related]
33. Identification of two amino acids in the hemagglutinin glycoprotein of measles virus (MV) that govern hemadsorption, HeLa cell fusion, and CD46 downregulation: phenotypic markers that differentiate vaccine and wild-type MV strains. Lecouturier V; Fayolle J; Caballero M; Carabaña J; Celma ML; Fernandez-Muñoz R; Wild TF; Buckland R J Virol; 1996 Jul; 70(7):4200-4. PubMed ID: 8676439 [TBL] [Abstract][Full Text] [Related]
34. Receptor (CD46) modulation and complement-mediated lysis of uninfected cells after contact with measles virus-infected cells. Schneider-Schaulies J; Schnorr JJ; Schlender J; Dunster LM; Schneider-Schaulies S; ter Meulen V J Virol; 1996 Jan; 70(1):255-63. PubMed ID: 8523534 [TBL] [Abstract][Full Text] [Related]